November 20, 2018, Las Vegas, Nevada. The Management of Cecors, Inc. (OTC: CEOS), is pleased to announce all filings have been made with OTC Markets to ensure the Company has current status with OTC Markets. Our corporate SEC Counsel has filed the required representation letter and Opinion, on the filings up to September 30, 2018.
The Company filings also reflect the following events. On May 11, 2017, the Company and Independent Living, mutually terminated the Term Sheet and Merger Agreement with Independent Living Products, Inc., dated November 20, 2016. Filings also reflect the resignation of Mr. Louis Orloff from the Board of Directors. The Company will also be seeking a civil complaint in the Miami, Florida courts to recover and cancel the 25,000,000 shares of common stock issued to Luca Sartini. The share delivery was based on the merger with Independent Living Products, Inc. The Company is confident that there will no dispute as to the return and/or cancelation of these shares.
On June 17, 2017, the Company entered into an Asset Purchase Agreement with Airam Capital Inc. (www.airamcapital.com) where it was agreed that Airam Capital, Inc. would transfer 100% of its development of intellectual property, patents, trademarks, and marketing of Telemedicine software application and web portal, https://www.youronlinemd.com.
About Cecors, Inc.
CeCors, Inc., http://www.cecorsinc.com, is engaged in the acquisition and development of Emerging Technologies as well as Healthcare & Data related companies. Its focus will be on the Health & Technology Sector as well as other Emerging Technologies, primarily on the mental health market through our investment and development of our TeleMed (Telemedicine) Network connecting patients with medical professionals. Using the same network, Cecors will also assist Medical Cannabis candidates by connecting them with physicians that will educate, diagnose and suggest appropriate treatment. See https://cannmedlive.com/
In the Health & Data sector, Cecors will exploit Big Data's direct connection to medical treatment & advancements with its investment and the development of its medical records management and portal companies. Further to this, we will be developing and utilizing Block chain technology to securely manage our big data so that it has a direct benefit to the patients by contributing to their health history. As the Company expands with the addition of new management, there will be a simultaneous expansion and entry into new technologies. The Company and its new management will continue to provide shareholder updates as we continue to focus on development and acquisition of substantial revenue producing entities into our company.